{"SPADE_UN_07619": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 5447914 A", "Patent Link": "http://www.lens.org/lens/patent/US_5447914_A", "Patent Type": "Granted Patent", "Publication Date": "1995-9-5", "Family Info": "CA2145313A1,CA2145313C,DE69331953D1,EP0665754A1,EP0665754A4,EP0665754B1,US5798336,WO1994007523A1", "Patent Title": "Antimicrobial peptides.", "Abstract": "Peptides which exhibit antimicrobial activity comparable to certain known antibiotics are provided. These peptides are related in sequence to amino acid sequences within Cathepsin G. A broad spectrum bactericidal peptide disclosed herein is RPGTLCTVAGWGRVSMRRGT (SEQ ID NO:22). It is active against Pseudomonas aeruginosa, Neisseria gonorrhoeae and Staphylococcus aureus. RRENTQQHITARRAIRHPQY (SEQ ID NO:19) and GKSSGVPPEVFTRFVSSFLPWIRTTMR (SEQ ID NO:20) also exhibited potent activity against P, aeruginosa strains, including clinical isolates. IIGGR (SEQ ID NO:1) and IVGGR (SEQ ID NO:2) act against both gram-negative and gram-positive bacterial strains. HPQYNQR (SEQ ID NO:3) and certain related peptides are also active against both gram-negative and gram-positive bacteria, including, but not limited to, strains of Escherichia coli, Neisseria gonorrhoeae, Staphylococcus aureus, Capnocytophage sputigena and Pseudomonas aeruginosa. The peptides of the present invention will be useful in pharmaceutical co"}, {"Patent No": "US 5798336 A", "Patent Link": "http://www.lens.org/lens/patent/US_5798336_A", "Patent Type": "Granted Patent", "Publication Date": "1998-8-25", "Family Info": "US4725576", "Patent Title": "Antimicrobial Peptides", "Abstract": "Peptides which exhibit antimicrobial activity comparable to certain known antibiotics are provided. These peptides are related in sequence to amino acid sequences within Cathepsin G. A broad spectrum bactericidal peptide disclosed herein is RPGTLCTVAGWGRVSMRRGT (SEQ ID NO,22). It is active against Pseudomonas aeruginosa, Neisseria gonorrhoeae and Staphylococcus aureus. RRENTQQHITARRAIRHPQY (SEQ ID NO,19) and GKSSGVPPEVFTRFVSSFLPWIRTTMR (SEQ ID NO,26) also exhibited potent activity against P. aeruginosa strains, including clinical isolates. IIGGR (SEQ ID NO,1) and IVGGR (SEQ ID NO,2) act against both gramnegative and grampositive bacterial strains. HPQYNQR (SEQ ID NO,3) and certain related peptides are also active against both gramnegative and grampositive bacteria, including, but not limited to, strains of Escherichia coli, Neisseria gonorrhoeae, Staphylococcus aureus, Capnocytophage sputigena and Pseudomonas aeruginosa. The peptides of the present invention will be useful in pharmaceutical compos"}], "Sequence Information": {"SPADE ID": "SPADE_UN_07619", "Sequence": "CTVAGWGRVSMRRGT", "Sequence Length": 15, "Peptide Name": "Sequence 39 from Patent US 5447914", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "GRT", "Absent Amino Acids": "DEFHIKLNOPQUY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 10, "Positive Residues": 3, "Negative Residues": 0, "Mass": 1636.9, "PI": 11.7, "Net Charge": 3, "Hydrophobicity": -0.21, "Similar Sequences": [{"SPADE_ID": "SPADE_N_08089", "Similarity": 1.0, "Sequence": "RPGTLRLCTVAGWGRVSMRRGT"}, {"SPADE_ID": "SPADE_UN_07603", "Similarity": 1.0, "Sequence": "RPGTLCTVAGWGRVSMRRGT"}, {"SPADE_ID": "SPADE_UN_07618", "Similarity": 1.0, "Sequence": "RPGLTLCTVAGWG"}]}}}